Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy

Lasers in Surgery and Medicine

Volumn 43, Issue 7, 2011, Pages 686-695

  Wang, Shouyan ^a   Fan, Wenzhe ^a   Kim, Gwangseong ^a   Hah, Hoe Jin ^a   Lee, Yong Eun Koo ^a   Kopelman, Raoul ^a   Ethirajan, Manivannan ^b   Gupta, Anurag ^b   Goswami, Lalit N ^b   Pera, Paula ^b   Morgan, Janet ^b   Pandey, Ravindra K ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

biodegradable; cancer treatment; HPPH; photodynamic therapy; polyacrylamide; post loading

Indexed keywords

2 (1 HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A; NANOCARRIER; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLYACRYLAMIDE; PORPHYRIN DERIVATIVE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CANCER THERAPY; CELL KILLING; COLON CARCINOMA; CONTROLLED STUDY; DISPERSION; DRUG CONJUGATION; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; MOUSE; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL;

ACRYLIC RESINS; ANIMALS; CELL LINE, TUMOR; CHLOROPHYLL; COLONIC NEOPLASMS; DRUG CARRIERS; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 80052054592     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21113     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R,. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2: 751-760. (Pubitemid 350223348)
3. Fayter D, Corbett M, Heirs M, Fox D, Eastwood A,. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess 2010; 14: 1-288.
4. O'Connor AE, Gallagher WM, Byrne AT,. Porphyrin and nonporphyrin in oncology: Preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009; 85: 1053-1074.
5. Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, Cheney RT, Morgan J,. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 2004; 64: 2120-2126. (Pubitemid 38339462)
6. Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ,. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol 2006; 57: 40-45. (Pubitemid 41704920)
7. Henderson BW, Bellnier DA, Greco WR, Sharma A, Pandey RK, Vaughan LA, Weishaupt KR, Dougherty TJ,. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res 1997; 57: 4000.
8. Pandey RK, Sumlin AB, Constantine S, Aoudia M, Potter WR, Bellnier DA, Henderson BW, Rodgers MA, Smith KM, Dougherty TJ,. Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacy. Photochem Photobiol 1996; 64: 194-204. (Pubitemid 26350479)
9. Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ,. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res 2003; 63: 1806-1813. (Pubitemid 36460841)
10. Furukawa K, Yamamoto H, Crean DH, Kato H, Mang TS,. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. Lasers Surg Med 1996; 18: 157-166. (Pubitemid 26064566)
11. Anderson TR, Dougherty TJ, Tan D, Sumlin A, Schlossin JM, Kanter PM,. Photodynamic therapy for sarcoma pulmonary metastases. Anticancer Res 2003; 23: 3713-3718.
12. Loewen G, Pandey R, Belliner D, Henderson B, Dougherty T,. Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med 2006; 38: 364-370.
13. Sunar U, Rohrbach D, Rigual N, Tracy E, Keymel K, Cooper MT, Baumann H, Henderson BW,. Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: A case report. Opt Express 2010; 18: 14969-14978.
14. Baba K, Pudavar HE, Roy I, Ohulchanskyy TY, Chen YH, Pandey RK, Prasad PN,. New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. Mol Pharm 2007; 4: 289-297. (Pubitemid 46640605)
15. Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, Ning J,. Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects. Adv Drug Deliv Rev 2008; 60: 939-954.
16. Koo YE L, Reddy GR, Bhojani M, Schneider R, Philbert MA, Rehemtulla A, Ross BD, Kopelman R,. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006; 58: 1556-1577. (Pubitemid 44820505)
17. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN,. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006; 3: 415-423. (Pubitemid 44351924)
18. Matsumura Y, Maeda H,. A new concept for macromolecular therapeutics in cancer chemotherapy-mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-6392. (Pubitemid 17221789)
19. Maeda H,. The enhanced permeability and retention (epr) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advan Enzyme Regul 2001; 41: 189-207.
20. Cheng Y, Samia AC, Meyers JD, Panagopoulos I, Fei BW, Burda C,. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 2008; 130: 10643-10647.
21. Yan F, Kopelman R,. The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties. Photochem Photobiol 2003; 78: 587-591.
22. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN,. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003; 125: 7860-7865. (Pubitemid 36782161)
23. Gao D, Agayan RR, Xu H, Philbert MA, Kopelman R,. Nanoparticles for two-photon photodynamic therapy in living cells. Nano Lett 2006; 6: 2383-2386. (Pubitemid 46076922)
24. Gao D, Xu H, Philbert MA, Kopelman R,. Ultrafine hydrogel nanoparticles: synthetic approach and therapeutic application in living cells. Ange Chem Int Ed 2007; 46: 2224-2227. (Pubitemid 46973620)
25. Tang W, Xu H, Kopelman R, Philbert MA,. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol 2005; 81: 242-249. (Pubitemid 40551499)
26. Tang W, Xu H, Park EJ, Philbert MA, Kopelman R,. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem Biophys Res Commun 2008; 369: 579-583.
27. Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN,. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc 2007; 129: 2669-2675. (Pubitemid 46364075)
28. Vargas A, Eid M, Fanchaouy M, Gurny R, Delie F,. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome. Eur J Pharm Biopharm 2008; 69: 43-53.
29. Moreno MJ, Monson E, Reddy RG, Rehemtulla A, Ross BD, Philbert M, Schneider RJ, Kopelman R,. Production of singlet oxygen by Ru(dpp(SO3)(2))(3) incorporated in polyacrylamide PEBBLES. Sens Actuator B Chem 2003; 90: 82-89.
30. Harrell JA, Kopelman R,. Biocompatible probes measure intracellular activity. Biophoton Int 2000; 7: 22.
31. Wenger Y, Schneider IIRJ, Reddy GR, Kopelman R, Jolliet O, Philbert MA,. Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. Toxicol Appl Pharmacol 2011; 251: 181-190.
32. Reddy GR, Bhojani MS, McConville P, Moody J, Moffat BA, Hall DE, Kim G, Koo YEL, Woolliscroft MJ, Sugai JV, Johnson TD, Philbert MA, Kopelman R, Rehemtulla A, Ross BD,. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006; 12: 6677-6686. (Pubitemid 44876835)
33. Lambert CR, Reddi E, Spikes JD, Rodgers MAJ, Jori G,. The effects of porphyrin structure and aggregation state on photosensitized processes in aqueous and micellar media. Photochem Photobiol 1986; 44: 595-601.
34. Kelbauskas L, Dietel W,. Internalization of aggregated photosensitizers by tumor cells: subcellular time-resolved fluorescence spectroscopy on derivatives of pyropheophorbide-a ethers and chlorin e6 under femtosecond one- and two-photon excitations. Photochem Photobiol 2002; 76: 686-694.
35. Zhang Y, Zhu W, Wang BB, Ding JD,. A novel microgel and associated post-fabrication encapsulation technique of proteins. J Controlled Release 2005; 105: 260.
36. Chiu HC, Lin YF, Hung SH,. Equilibrium swelling of copolymerized acrylic acid-Methacrylated dextran networks: Effects of pH and neutral salt. Macromolecules 2002; 35: 5235-5242.
37. Tan HP, Chu CR, Payne KA, Marra KG,. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 2009; 30: 2499-2506.
38. Pallenberg AJ, Dobhal MP, Pandey RK,. Efficient synthesis of pyropheophorbide-a and its derivatives. Org Proc Res Dev 2004; 8: 287-290. (Pubitemid 38453179)